强直性脊柱炎中西医结合医疗质量控制指标专家共识(2021版)

2021-04-20 中日友好医院学报.2021.35(2):67-69.

强直性脊柱炎(AS)属中医“大偻”范畴,中西医结合方法在AS 的治疗中发挥重要作用,能够显著改善患者症状,提高生活质量。但目前AS 中西医结合医疗质量控制体系尚未建立。由中日友

中文标题:

强直性脊柱炎中西医结合医疗质量控制指标专家共识(2021版)

发布机构:

发布日期:

2021-04-20

简要介绍:

强直性脊柱炎(AS)属中医“大偻”范畴,中西医结合方法在AS 的治疗中发挥重要作用,能够显著改善患者症状,提高生活质量。但目前AS 中西医结合医疗质量控制体系尚未建立。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科牵头,以北京中西医结合学会风湿病分会为依托,采用德尔菲法制定了《强直性脊柱炎中西医结合医疗质量控制指标》专家共识(北京中西医结合学会标准化专家共识备案号:2021Z031A2),共9 个条目,涵盖了AS 患者住院期间或门诊随访时需要进行的诊疗、生活质量评估医疗质量控制指标。本共识的制定将为我国AS 中西医结合医疗质量控制提供参考,将有助于改善AS 的诊治现状。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=强直性脊柱炎中西医结合医疗质量控制指标专家共识_2021版_陶庆文.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c99cc1c002092207, title=强直性脊柱炎中西医结合医疗质量控制指标专家共识(2021版), enTitle=, guiderFrom=中日友好医院学报.2021.35(2):67-69., authorId=0, author=, summary=强直性脊柱炎(AS)属中医“大偻”范畴,中西医结合方法在AS 的治疗中发挥重要作用,能够显著改善患者症状,提高生活质量。但目前AS 中西医结合医疗质量控制体系尚未建立。由中日友, cover=https://img.medsci.cn/202155/1620228406693_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue Apr 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>强直性脊柱炎(AS)属中医&ldquo;大偻&rdquo;范畴,中西医结合方法在AS 的治疗中发挥重要作用,能够显著改善患者症状,提高生活质量。但目前AS 中西医结合医疗质量控制体系尚未建立。由中日友好医院中西医结合医学中心发起,中日友好医院中医风湿病科牵头,以北京中西医结合学会风湿病分会为依托,采用德尔菲法制定了《强直性脊柱炎中西医结合医疗质量控制指标》专家共识(北京中西医结合学会标准化专家共识备案号:2021Z031A2),共9 个条目,涵盖了AS 患者住院期间或门诊随访时需要进行的诊疗、生活质量评估医疗质量控制指标。本共识的制定将为我国AS 中西医结合医疗质量控制提供参考,将有助于改善AS 的诊治现状。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1546, tagName=强直性脊柱炎)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1546, guiderKeyword=强直性脊柱炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14533, appHits=368, showAppHits=0, pcHits=1124, showPcHits=14165, likes=4, shares=20, comments=17, approvalStatus=1, publishedTime=Wed May 05 23:31:56 CST 2021, publishedTimeString=2021-04-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed May 05 23:26:53 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:26:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=强直性脊柱炎中西医结合医疗质量控制指标专家共识_2021版_陶庆文.pdf)])
强直性脊柱炎中西医结合医疗质量控制指标专家共识_2021版_陶庆文.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070382, encodeId=7b6c10e0382c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a25423662, createdName=ms2000000289637663, createdTime=Mon Nov 15 11:56:22 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065230, encodeId=1d251065230b3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/4bdaca68847c4d2e99b91d36bd3a3aa5/4f9da8f2731d43789f9275daf226d137.jpg, createdBy=328b5648431, createdName=ms4000000446951766, createdTime=Sat Oct 30 09:55:17 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057705, encodeId=4d1b105e705dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68355624696, createdName=ms3000001242860108, createdTime=Mon Oct 04 22:53:15 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015288, encodeId=a4f11015288b3, content=最前沿的资讯。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22de5597234, createdName=ms4000001508930487, createdTime=Tue Sep 07 09:30:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012352, encodeId=b26a10123524a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace95383736, createdName=ms2000000939483150, createdTime=Sat Aug 28 18:08:50 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-11-15 ms2000000289637663

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070382, encodeId=7b6c10e0382c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a25423662, createdName=ms2000000289637663, createdTime=Mon Nov 15 11:56:22 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065230, encodeId=1d251065230b3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/4bdaca68847c4d2e99b91d36bd3a3aa5/4f9da8f2731d43789f9275daf226d137.jpg, createdBy=328b5648431, createdName=ms4000000446951766, createdTime=Sat Oct 30 09:55:17 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057705, encodeId=4d1b105e705dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68355624696, createdName=ms3000001242860108, createdTime=Mon Oct 04 22:53:15 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015288, encodeId=a4f11015288b3, content=最前沿的资讯。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22de5597234, createdName=ms4000001508930487, createdTime=Tue Sep 07 09:30:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012352, encodeId=b26a10123524a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace95383736, createdName=ms2000000939483150, createdTime=Sat Aug 28 18:08:50 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-10-30 ms4000000446951766

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070382, encodeId=7b6c10e0382c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a25423662, createdName=ms2000000289637663, createdTime=Mon Nov 15 11:56:22 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065230, encodeId=1d251065230b3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/4bdaca68847c4d2e99b91d36bd3a3aa5/4f9da8f2731d43789f9275daf226d137.jpg, createdBy=328b5648431, createdName=ms4000000446951766, createdTime=Sat Oct 30 09:55:17 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057705, encodeId=4d1b105e705dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68355624696, createdName=ms3000001242860108, createdTime=Mon Oct 04 22:53:15 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015288, encodeId=a4f11015288b3, content=最前沿的资讯。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22de5597234, createdName=ms4000001508930487, createdTime=Tue Sep 07 09:30:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012352, encodeId=b26a10123524a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace95383736, createdName=ms2000000939483150, createdTime=Sat Aug 28 18:08:50 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-10-04 ms3000001242860108

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070382, encodeId=7b6c10e0382c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a25423662, createdName=ms2000000289637663, createdTime=Mon Nov 15 11:56:22 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065230, encodeId=1d251065230b3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/4bdaca68847c4d2e99b91d36bd3a3aa5/4f9da8f2731d43789f9275daf226d137.jpg, createdBy=328b5648431, createdName=ms4000000446951766, createdTime=Sat Oct 30 09:55:17 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057705, encodeId=4d1b105e705dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68355624696, createdName=ms3000001242860108, createdTime=Mon Oct 04 22:53:15 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015288, encodeId=a4f11015288b3, content=最前沿的资讯。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22de5597234, createdName=ms4000001508930487, createdTime=Tue Sep 07 09:30:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012352, encodeId=b26a10123524a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace95383736, createdName=ms2000000939483150, createdTime=Sat Aug 28 18:08:50 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-09-07 ms4000001508930487

    最前沿的资讯。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1070382, encodeId=7b6c10e0382c5, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a25423662, createdName=ms2000000289637663, createdTime=Mon Nov 15 11:56:22 CST 2021, time=2021-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065230, encodeId=1d251065230b3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/4bdaca68847c4d2e99b91d36bd3a3aa5/4f9da8f2731d43789f9275daf226d137.jpg, createdBy=328b5648431, createdName=ms4000000446951766, createdTime=Sat Oct 30 09:55:17 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057705, encodeId=4d1b105e705dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68355624696, createdName=ms3000001242860108, createdTime=Mon Oct 04 22:53:15 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015288, encodeId=a4f11015288b3, content=最前沿的资讯。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22de5597234, createdName=ms4000001508930487, createdTime=Tue Sep 07 09:30:21 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012352, encodeId=b26a10123524a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ace95383736, createdName=ms2000000939483150, createdTime=Sat Aug 28 18:08:50 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 ms2000000939483150

    学习了

    0

拓展阅读

2010 依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议

中国风湿免疫科相关专家小组(统称) · 2010-06-30

2010版 强直性脊柱炎诊断及治疗指南

中华医学会风湿病学分会(CRA,Chinese Rheumatology Association) · 2010-08-01

2010年更新的ASAS/ EULAR对强直性脊柱炎的治疗指南意见

国际评估强直性脊柱炎工作组(ASAS,ASsessment in Ankylosing Spondylitis international Society) · 2011-01-01

2011 NICE 强直性脊柱炎--戈利木单抗用药指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-08-24

2012 强直性脊柱炎的诊断与治疗骨科专家共识

中国骨科相关专家小组(统称) · 2012-09-01

依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议(2013)

中国风湿免疫科相关专家小组(统称) · 2013-05-14